"On December 17, 2021, the United State Environmental Protection Agency (USEPA) published the final Unregulated Contaminants Monitoring Rule 5 (UCMR5). This 5th UCMR will require monitoring of the drinking water entry points of public water systems across the nation for selected Per- and Polyfluoroalkyl substances (PFAS) and Lithium. To assist our water system customers plan for a successful implementation of the UCMR5 requirements, we will project a detailed overview of the Rule requirements, including key milestones, deadlines plus opportunities for efficiency and cost savings."

"Compliance is often driven by three different motivators: technical excellence, teamwork, and consequences. The more the lab can generate a culture of high-quality science, and build the respect and inclusion of the team, the less the lab manager needs to resort to consequences to ensure the high quality of the science delivered by the lab.

In this presentation, we intend to cover the following topics:

* Defining the quality processes required by the lab
* Communicating the importance of quality
* Defining appropriate quality standards and policies to ensure high-quality outcomes
* Cultivating a lab culture that will deliver high quality science and reinforce cohesive teamwork
* When consequences are required for compliance"

"This webinar will describe new antibiotics used to target multi-drug resistant gram positive and gram-negative bacteria. In addition, to a general description of the antibiotics, we will discuss common clinical scenarios in which these antibiotics might be prescribed. Finally, this webinar will describe options available to clinical microbiology laboratories for performing susceptibility testing and discuss the pros and cons of performing this testing.

A certificate of participation will be granted to each participant based on 1.0 contact hours of instruction toward credit."

"Most of us have never known a time when policies that affect our everyday change so frequently. Early in the COVID-19 pandemic, leaders in all walks of life were forced to make policy decisions based on limited data. Two years on and several waves of infection later, many health systems have developed noteworthy COVID dashboards that utilize data graphics to visually display information for sound public health policymaking.

Join in for several perspectives on public health data management, including data acquisition, data analysis, data display and the resulting development of COVID policies for the hospital and beyond."

"Most laboratory informatics environments require a diverse number of applications each with distinct functions (e.g., sample management, instrument control, data acquisition and interpretation, calculation and reporting of results). The main aims of such informatics applications are to meet regulatory compliance and data integrity objectives; however, hybrid systems can present major challenges for laboratories.

A laboratory automation/digitisation strategy, alongside senior management support, funding and resourcing, is crucial for defining the steps required to automate the laboratory over several phases. The objective of this webcast is to highlight ways to ensure that your investments in laboratory informatics applications are sound and long-lasting."

"During this COCA Call, CDC experts will present:

* Updated recommendations on COVID-19 vaccines for people who are moderately or severely immunocompromised,
* Simplified recommendations for vaccination following receipt of passive antibody therapy, and
* Summarized recommendations for COVID-19 vaccination by age group."

"Candida auris is an emerging fungus that poses a serious threat to global health. In this session, we’ll review the characteristics of C. auris, discuss its prevalence, and review strategies for diagnosis, treatment, and prevention.

Objectives:

* Describe the characteristics of C. auris that make this organism a serious global health concern
* Discuss the number of reported clinical cases in both the United States and worldwide
* Explain the current strategies for diagnosis and treatment and the limitations to these strategies
* Assess current research and the future needs in the fight against C. auris"

"This webinar describes methods that are recommended to standardize the detection and measurement of the monoclonal proteins in different laboratories for the detection and initial diagnosis of monoclonal gammopathies. A monoclonal gammopathy is any disorder marked by proliferation of an abnormal clone (or clones) of a plasma cell or B cell in the bone marrow resulting in an abnormal increase of proteins in the blood serum and urine."

Wednesday March 2, 2022 at 11:00 am EST

Case management is one of the most challenging areas for nursing and occupational safety management professionals to navigate. Often, due to lack of resources and access to the right solution for effectively navigating a case, what usually starts out as a minor case can quickly escalate into a major liability.

Join our free webinar titled: Redefining Your Case Management Process in Today’s All Digital World
on March 2, 2022 at 11:00 am EST and gain exclusive insights from leading EHS leaders and workers’ comp professionals.

Participants will get the best strategies and information on workers’ compensation management that will help get your EHS claims, program, and costs under control. You can now reduce your organization’s workers’ compensation costs while increasing efficiencies and economies of scale to you and your clients.

Register now and take your first step in leveraging your EHS performance for better business outcomes and worker’s compensation today.

"This session will outline steps to effectively navigate severe neutropenia in pediatric patients. Treatment options based upon laboratory findings and other test results will be reviewed. Interesting case studies will be shared highlighting the clinical work-up of neutropenia in this challenging patient population."

"After watching this webinar, the participant will be able to:

* Discuss the clinical evaluation of children presenting with severe neutropenia.
* State how the results of laboratory testing inform the treatment of neutropenia in pediatric patients.
* Recognize the work- up of neutropenia based upon case study review."

"Clinical laboratories face a complex demand to provide and receive information from a variety of sources. New Interoperability technology allows the laboratory to build a generic, cost effective process to handle new patient, and order requests, and provide results directly to patients, providers, and health systems, without the need of point-to-point interfaces. In this session we will review the required technology and discuss its implementation from the laboratory perspective. Technology requirements for infrastructure, data communications, business logic, and lab application data flow will be reviewed. This review will also discuss the impact to cost of lab IT and related support staff requirements."

"Clinical teams have been under increasing pressure to bring life-saving therapies to market quickly. But often clinical teams are burdened by an abundance of clinical assets spread across multiple solutions and across multiple teams from CROs to sponsors to labs, making it difficult to streamline any communication or progress.

That’s where Box comes in. The Box Content Cloud makes collaboration across external alliances such as CROs, sponsors, labs easy with real-time sharing of regulated and non-regulated content on one platform. Join the webinar Clinical Collaboration made easy with the Content Cloud to learn how clinical teams can:

● Speed up research exchange of regulated and unregulated clinical assets between sponsors and external alliances such as CROs or research partners
● Securely monitor clinical sites and verify source documents with GxP validation, granular permissions, and data governance
● Improve researcher collaboration on clinical (SAS) datasets when working with programmers and data managers"

"SARS-CoV-2 causes COVID-19, a potentially lethal viral infection that can cause severe pneumonia, long-term adverse effects to several organ systems, and death in some individuals. Since the infection was first reported at the end of 2019, the entire world has endured widespread infection and the global diagnostics and biopharmaceutical industries have mobilized to create diagnostic tests, antiviral drugs, and vaccines to help combat this global pandemic. The objectives of this presentation are (1) to provide an update on the COVID-19 pandemic, (2) to discuss SARS-CoV-2 variants with respect to both spread and virulence, (3) to review the current SARS-CoV-2 vaccines in terms of both efficacy and limitations, and (4) to review the types of SARS-CoV-2 tests that are available. The final part of the presentation will review what has been most important during the first two years of the pandemic and discuss what will be most important going forward. The overall goal is for the audience to have an up-to-date understanding of the epidemiology, virology, vaccination, and testing for SARS-CoV-2 and COVID-19 and what to look forward to in the coming year as we work together to manage this very serious challenge to global health."